Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Acta 137 OrreniusS.GogvadzeV.ZhivotovskyB
Litigation between Novo, Mylan and Viatris and Sun Pharmaceutical Industries with respect to the patents protecting Wegovy is still ongoing
Phase 1: The Is This Thing On? Phase (Weeks 14) This is where most people quit
The program gives employers a more practical way to support GLP-1 coverage with: manufacturer net pricing employer-controlled benefit design PBM-native claims integration clinical and safety checks one-to-one support from LucyRx Care Guides The goal is simple: help employers say yes to GLP-1 coverage with clearer pricing, operational control, and a member experience that does not create another disconnected path to care
US$ 29.57
US$ 22.97
US$ 24.15
US$ 22.90
